70 related articles for article (PubMed ID: 6619643)
1. [Human lymphoblast interferon. An effective agent on renal cell carcinoma].
Ono Y; Ohshima S; Fujita T; Asano H; Naide Y; Suzuki K; Aso Y; Ariyoshi Y; Fukushima M; Ota K
Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):962-8. PubMed ID: 6619643
[No Abstract] [Full Text] [Related]
2. [Effect of recombinant alpha-interferon on advanced renal cell carcinoma].
Isaka S; Okano T; Akimoto S; Shimazaki J; Murakami S; Igarashi T; Kitamura Y; Yamaguchi K; Kataumi S; Ohtsuka K
Hinyokika Kiyo; 1985 Dec; 31(12):2209-14. PubMed ID: 3832921
[TBL] [Abstract][Full Text] [Related]
3. Interferon and doxorubicin in renal cell carcinoma.
Muss HB; Welander C; Caponera M; Reavis K; Cruz JM; Cooper MR; Jackson DV; Richards F; Stuart JJ; Spurr CL
Cancer Treat Rep; 1985 Jun; 69(6):721-2. PubMed ID: 4016777
[No Abstract] [Full Text] [Related]
4. [The therapy of renal cell carcinoma with human lymphoblastoid interferon].
Masuda F; Suzuki M; Ikemoto I; Yamazaki H; Machida T
Hinyokika Kiyo; 1984 May; 30(5):615-9. PubMed ID: 6206703
[TBL] [Abstract][Full Text] [Related]
5. The treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
Kotake T; Kinouchi T
Prog Clin Biol Res; 1989; 303():661-9. PubMed ID: 2780667
[No Abstract] [Full Text] [Related]
6. [Phase II trial of treatment of metastatic renal adenocarcinoma with recombinant leukocyte interferon (rDNA IFN-alpha 2)].
Dorval T; Palangie T; Garcia-Giralt E; Jouve M; Bretaudeau B; Falcoff F; Coninx P; Schwab D; Pouillart P
Bull Cancer; 1985; 72(5):470-1. PubMed ID: 4074917
[No Abstract] [Full Text] [Related]
7. [Clinical efficacy of interferon-beta (MR-21) in renal cell carcinoma and cancer of the bladder].
Niijima T
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):928-33. PubMed ID: 3694001
[No Abstract] [Full Text] [Related]
8. Alpha interferon therapy for renal cell carcinoma: summary of four collaborative trials. Cancer Research Committee.
Aso Y; Umeda T; Niijima T
Prog Clin Biol Res; 1989; 303():653-9. PubMed ID: 2675017
[No Abstract] [Full Text] [Related]
9. [The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors].
Tsubura E
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1049-58. PubMed ID: 3463630
[No Abstract] [Full Text] [Related]
10. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
11. Clinical investigation of partially pure and recombinant DNA derived leukocyte interferon in human cancer.
Gutterman J; Quesada J
Tex Rep Biol Med; 1981-1982; 41():626-33. PubMed ID: 6763369
[No Abstract] [Full Text] [Related]
12. [Therapy of renal cell carcinoma. 3. Interferon therapy].
Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: antitumor effects of leukocyte interferon.
Quesada JR; Swanson DA; Trindade A; Gutterman JU
Cancer Res; 1983 Feb; 43(2):940-7. PubMed ID: 6336662
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon].
Ryu S; Fukuoka M; Tamai S; Takifuji N; Sakai N; Matsui K; Negoro S; Takada M; Kusunoki Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):996-1002. PubMed ID: 3694004
[No Abstract] [Full Text] [Related]
16. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
Rinehart J; Malspeis L; Young D; Neidhart J
Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
[TBL] [Abstract][Full Text] [Related]
17. [A study of the clinical response of renal cell carcinoma to human lymphoblastoid interferon (MOR-22)].
Niijima T
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1277-84. PubMed ID: 3782978
[No Abstract] [Full Text] [Related]
18. [A case of pulmonary metastasis from renal cell carcinoma in which complete remission was achieved by interferon therapy (r-IFN-alpha A, Ro 22-8181)].
Ishito N; Wada F; Aramaki K; Asano S; Johsen T
Gan To Kagaku Ryoho; 1986 Feb; 13(2):380-3. PubMed ID: 3947113
[TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
